INTRODUCTION
============

In higher eukaryotes, pre-mRNA splicing is mediated by degenerative splicing *cis*-elements comprised of the branch point sequence (BPS), the polypyrimidine tract (PPT), the 5′ and 3′ splice sites and exonic/intronic splicing enhancers/silencers. Stepwise assembly of the spliceosome starts from recruitment of U1 snRNP, SF1, U2AF65 and U2AF35 to the 5′ splice site, the branch site, the PPT and the 3′ end of an intron, respectively (Complex E). SF1, a 75-kDa polypeptide, is a mammalian homolog of yeast BBP (branch point-binding protein). U2AF65 and U2AF35 bring U2snRNP to the BPS in place of SF1 ([@B1],[@B2]). The BPS establishes base pairing interactions with a stretch of 'GUAGUA' of U2 snRNA ([@B3],[@B4]), which then bulges out the branch site nucleotide, usually an adenosine (Complex A) ([@B5]). Thereafter, pre-mRNAs are spliced in two sequential transesterification reactions mediated by the spliceosome. In the first step, the 2′-OH moiety of the branch site nucleotide carries out a nucleophilic attack against a phosphate at the 5′ splice site, generating a free upstream exon, as well as a lariat carrying the intron and the downstream exon. In the second step, the 3′-OH moiety of the upstream exon attacks the 3′ splice site leading to intron excision and ligation of the upstream and downstream exons ([@B6]). The branch site is thus involved in the first step of splicing, and potentially in the second step of splicing, although the detailed molecular mechanisms of contribution to the second step remain elusive ([@B7]).

The BPS is strictly conserved in yeast and has the sequence of UACUA[A]{.ul}C, where the branch point adenosine is underlined. On the other hand, the human BPSs are degenerative. No extensive *in vitro* identification of human BPSs has been reported. Five communications address the mammalian consensus BPSs ([Table 1](#T1){ref-type="table"}). Three reports are based on 11--20 *in vitro* identified BPSs, and two are dependent on the *in silico* analysis of the human genome. Table 1.Previously reported consensus BPSsConsensus BPSNoteReferences*S. cerevisiae*UACUA[A]{.ul}CInvariant BPS([@B36],[@B37])MammalsYNYUR[A]{.ul}Y11 mammalian BPSs([@B25])YNCUR[A]{.ul}C20 mammalian BPSs([@B38])YNCUR[A]{.ul}Y15 BPSs of human HBB([@B39])CUR[A]{.ul}Y*In silico* homology search([@B40])YUV[A]{.ul}Y[^a^](#TF1){ref-type="table-fn"} CUS[A]{.ul}Y[^b^](#TF2){ref-type="table-fn"}*In silico* homology search([@B41])[^1][^2][^3]

In an effort to establish the human consensus BPS based on *in vitro* experiments, we analyzed 367 clones of lariat RT-PCR products arising from 52 introns of 20 human housekeeping genes. We found that the human consensus BPS is yUn[A]{.ul}y. Our analysis demonstrates that the human BPSs are more degenerative than we have expected and that the BPS is likely recognized in combination with the PPT and/or the other splicing *cis*-elements.

MATERIALS AND METHODS
=====================

Lariat RT-PCR primers for human housekeeping genes
--------------------------------------------------

Among the 575 human housekeeping genes registered at <http://www.compugen.co.il/supp_info/Housekeeping_genes.html> ([@B8]), we excluded 82 genes, for which we could not find entries in the EST profile viewer of the NCBI UniGene database (<http://www.ncbi.nlm.nih.gov/UniGene/>). Among 4188 introns of the remaining 493 human housekeeping genes, we excluded introns with a size of less than 300 nucleotides or with multiple repeated segments, because it was difficult to design appropriate PCR primers for such introns. We next sorted the 493 genes in the order of skin expression levels according to the EST profile viewer, and picked up the 20 best genes. We thus analyzed 52 introns of the 20 human housekeeping genes ([Supplementary Table 1](http://nar.oxfordjournals.org/cgi/content/full/gkn073/DC1)).

We placed the sense primers at least 100 nucleotides upstream of the 3′ end of an intron, and the antisense primers at least 10 nucleotides downstream of the 5′ end of an intron. The melting temperatures of the primers were designed to be 64--67°C according to the nearest neighbor method. Gene symbols, intron numbers and primer sequences are indicated in [Supplementary Table 1](http://nar.oxfordjournals.org/cgi/content/full/gkn073/DC1).

Lariat RT-PCR to identify the branch point
------------------------------------------

We performed nested lariat RT-PCR to amplify a fragment spanning the 2′--5′ phosphodiester bond at the branch point ([@B9]). We isolated total RNA from HEK293 cells grown to confluency in DMEM medium (Sigma-Aldrich) supplemented with 10% fetal bovine serum (Sigma-Aldrich) and penicillin--streptomycin (Invitrogen). First-strand cDNA was synthesized with SuperScript II reverse transcriptase (Invitrogen) using an intron-specific antisense primer C ([Figure 1](#F1){ref-type="fig"}) located close to the 5′ end of an intron. The first round of lariat RT-PCR was performed using primers C and D with *Taq* HS DNA polymerase (Takara) in 25 µl. The nested lariat RT-PCR was carried out with primers A and B using 0.2 µl of the first-round lariat RT-PCR product in 50 µl. The first-round PCR program was comprised of an initial denaturation step at 94°C for 3 min, followed by 30 cycles of 94°C for 30 s, 55°C for 30 s and 72°C for 1 min. For the nested PCR, we performed 35 cycles of amplification. Figure 1.(**A**) Lariat RT-PCR of *PGK1* intron 6 indicates a misincorporated 'A' nucleotide at the branch point. We can pinpoint the branch point in this situation. The sequencing is performed with primer B. The small dots indicate the 5′ end of an intron. (**B**) Lariat RT-PCR of *GAPDH* intron 2 exhibits no misincorporated nucleotide. The branch point can be either at 'C' or upstream 'T' depending on whether skipping of the reverse transcriptase occurs or not. We cannot locate the exact branch point in this case. The sequencing is performed with primer A.

We purified the nested lariat RT-PCR products using the Wizard SV Gel and PCR Clean-up system (Promega), and cloned them into the pGEM-T-Easy vector (Promega). We sequenced 10 clones for each intron using the CEQ8000 genetic analyzer (Beckman Coulter).

Presentations of sequence motifs
--------------------------------

Sequence motifs are presented using the Pictogram web server at <http://genes.mit.edu/pictogram.html> ([@B10]).

To indicate the amount of information conferred by each nucleotide at each position, we employed the WebLogo program at <http://weblogo.berkeley.edu/> ([@B11],[@B12]). We also calculated the total amount of information content at each position using the following formula: where *Pi* represents the probability of nucleotide *i* at each position. *R*~sequence~ represents the degree of conservation of a sequence motif at a specific position ([@B13]). It becomes 2.0 when a single nucleotide is exclusively observed at a specific position, whereas it becomes 0.0 when four nucleotides are evenly observed.

RESULTS
=======

Collation of previously identified mammalian BPSs
-------------------------------------------------

As shown in [Table 1](#T1){ref-type="table"}, five communications address the mammalian consensus BPSs. In order to understand the *in vitro* determined mammalian consensus BPS, we collated 29 previously reported BPSs comprised of 25 mammalian and four viral introns ([Table 2](#T2){ref-type="table"}). Viral introns should be spliced in the same way as the mammalian genes. The branch points are located between positions −38 to −4 (mean and SD, −26.9 ± 7.8). Nucleotides 'C', 'U', 'A' and 'Y' at positions −3, −2, 0 and +1 are observed at 21 (72.4%), 21 (72.4%), 23 (79.3%) and 25 sites (86.2%), respectively. The deduced consensus BPS thus becomes CUn[A]{.ul}y at positions −3 to +1 ([Figure 2](#F2){ref-type="fig"}A and B), when we arbitrarily assume that positions with the information contents above 0.45 are significant. Figure 2.Pictogram (**A**, **C** and **E**) and WebLogo (**B**, **D** and **F**) presentations of mammalian BPSs. (**A** and **B**) Twenty-nine mammalian and viral BPSs identified by *in vitro* experiments ([Table 2](#T2){ref-type="table"}). (**C** and **D**) BPSs with a misincorporated nucleotide at the branch point in our studies. (**E** and **F**) BPSs without a misincorporated nucleotide at the branch point in our studies. We assume that 'A' residue one or two nucleotides downstream of the sequenced branch point is the actual branch point (see [Figure 1](#F1){ref-type="fig"}B). Position 0 represents the branch point. Table 2.Previously identified mammalian and viral BPSsSpeciesGeneIntronBPSPositionPredicted BP[^a^](#TF3){ref-type="table-fn"}BPS Score[^a^](#TF3){ref-type="table-fn"}ReferenceH. sapiens*CALCA*4CACTC[A]{.ul}C−36^b^−36A3.85([@B42])H. sapiens*CALCA*3TACTG[T]{.ul}C−23^b^−42A2.60([@B21])H. sapiens*CALCA*3GTACT[G]{.ul}T−24^b^−42A2.60([@B21])H. sapiens*CALCA*3GGTGC[A]{.ul}T−32^b^−42A2.60([@B21])H. sapiens*CSH1*1CCTCC[A]{.ul}T−23^b^−23A2.75([@B22])H. sapiens*DQB1*3CACAG[A]{.ul}C−21^c^−21A3.25([@B17])H. sapiens*GH1*1CTCTG[T]{.ul}T−22^b^nana([@B22])H. sapiens*GH1*1GGCTC[C]{.ul}C−28^b^nana([@B22])H. sapiens*GH1*1TGCTC[T]{.ul}C−36^b^nana([@B22])H. sapiens*GH1*4GCCTC[T]{.ul}C−24^b^−37A2.80([@B22])H. sapiens*GH1*4ACCCA[A]{.ul}G−37^b^−37A2.80([@B22])H. sapiens*GH1*4TACCC[A]{.ul}A−38^b^−37A2.80([@B22])H. sapiens*HBA*1CCCTC[A]{.ul}C−19^b^−37A3.25([@B25])H. sapiens*HBA*2CACTG[A]{.ul}C−18^b^−18A3.95([@B25])H. sapiens*HBB*1CACTG[A]{.ul}C−37^b^−37A3.95([@B25])H. sapiens*HBE1*1CTCTA[A]{.ul}T−31^b^−31A3.45([@B25])H. sapiens*HBG1*1TTCTG[A]{.ul}C−30^b^−30A3.85([@B25])H. sapiens*MYH10*5TGCTA[A]{.ul}C−31^b^nana([@B15])H. sapiens*XPC*3TGTTG[A]{.ul}T−4^b^nana([@B16])H. sapiens*XPC*3TACTG[A]{.ul}T−24^b^nana([@B16])M. musculus*Hbb-b2*1CACTA[A]{.ul}C−36^b^−36A3.85([@B25])M. musculus*Igh*5AATTC[A]{.ul}C−22^b^−22A3.30([@B14])R. norvesicus*Ins1*1CCTCA[A]{.ul}C−18^b^−18A3.15([@B25])O. cuniculus*Hbb*1TGCTG[A]{.ul}C−34^b^−34A3.85([@B25])O. cuniculus*Hbb*2TGCTA[A]{.ul}C−32^b^−32A3.75([@B28])Adenovirus 5*E1A*1GTTTA[A]{.ul}A−30^b^−30A2.70([@B25])Adenovirus 2*E2a-2*1GACTG[A]{.ul}C−26^b^−26A3.70([@B42])Adenovirus 5*Major Late*1TACTT[A]{.ul}T−24^b^−24A3.05([@B42])SV40*T antigen*1ATTCT[A]{.ul}A−19^b^−19A2.00([@B42])[^4][^5][^6]

Lariat RT-PCR with or without a misincorporated nucleotide at the branch point
------------------------------------------------------------------------------

To further explore the human consensus BPS, we chose 52 introns of 20 human housekeeping genes. We performed nested lariat RT-PCR and cloned the amplified products. We sequenced ten clones from each intron, and 367 clones carried available inserts, which represented 117 possible branch sites ([Table 3](#T3){ref-type="table"}). The remaining 153 clones carried either no inserts or PCR artifacts. Table 3.Analyzed introns and observed branch pointsGeneIntronIntron size (bp)Predicted BP[^a^](#TF6){ref-type="table-fn"}BPS Score[^a^](#TF6){ref-type="table-fn"}Observed BPNumber of clonesMisincorporated nucleotideIntronic sequence from BPS position −5 to the 3′ end of an intron[^b^](#TF7){ref-type="table-fn"}*ACTB*3441−24A3.10−30A10--TCCCC[A]{.ul}GTGTGACATGGTGTATCTCTGCCTTACAG*ALOD*8984−24A3.05−26T2--TGTCT[T]{.ul}AATGTTGTTACCCTGACCCCAACAG−25A2TGTCTT[A]{.ul}ATGTTGTTACCCTGACCCCAACAG−5A1--ACCCC[A]{.ul}ACAG*CCT3*41069−21A3.30−32A3--TGAAT[A]{.ul}GTGTGAATTCACTAGTGATCTACC TTTTTAG−30T1--AATAG[T]{.ul}GTGAATTCACTAGTGATCTACCTTTTTAG−21A2TAATTC[A]{.ul}CTAGTGATCTACCTTTTTAG*CCT3*11845−44A2.95−24A6TGCTTC[A]{.ul}TACTGTCTGTTTGCTTCTCCAAG−10C1--GTTTG[C]{.ul}TTCTCCAAG*EEF1A1*2366−24A2.80−28A2TTAGTA[A]{.ul}CCAAGTAACGACTCTTAATCCTTACAG−19C1--AGTAA[C]{.ul}GACTCTTAATCCTTACAG*EEF1A1*1943−33A3.25−23A10TGGTTC[A]{.ul}AAGTTTTTTTCTTCCATTTCAG*ENO1*22837−33A3.25−27T6--ATTGC[T]{.ul}ACTACATCTTTTTTCCTCTCATCCAG−25C2TTGCTA[C]{.ul}TACATCTTTTTTCCTCTCATCCAG*ENO1*42394−21A3.45−21A10TCCCTC[A]{.ul}TTCTCCCCTCTCCCTCGTAG*ENO1*5737−32A3.20−27A6TACTTC[A]{.ul}TTCCACTCGGTTCTCTTCTGTTCTAG−24C1--TCATT[C]{.ul}CACTCGGTTCTCTTCTGTTCTAG*ENO1*6615−36A2.85−30T2GCCCAG[T]{.ul}GCCATGCTTCTCTGCTCTGCTCTCCCCAG−27C3AAGTGC[C]{.ul}ATGCTTCTCTGCTCTGCTCTCCCCAG−26A3--GTGCC[A]{.ul}TGCTTCTCTGCTCTGCTCTCCCCAG*ENO1*7796−25A3.05−38A3TTACCT[A]{.ul}CCTGTTTTCCAAACCTGTTGTCACCATC TCTTCCCAG−28C1--TTTTC[C]{.ul}AAACCTGTTGTCACCATCTCTTCCCAG−27A2TTTTCC[A]{.ul}AACCTGTTGTCACCATCTCTTCCCAG−26A2TTTCCA[A]{.ul}ACCTGTTGTCACCATCTCTTCCCAG*ENO1*9547−30A2.70−5T2ATGGCT[T]{.ul}CCAG*ENO1*111457−26A2.95−48T4--AGGTC[T]{.ul}GACTTTTCTTTTTTCCTCCCCATCTCTTTACC TTTCTCCTTCCCAAG−47G2--GGTCT[G]{.ul}ACTTTTCTTTTTTCCTCCCCATCTCTTT ACCTTTCTCCTTCCCAAG−46A3TGTCTG[A]{.ul}CTTTTCTTTTTTCCTCCCCATCTCTTTACC TTTCTCCTTCCCAAG*G22P1*16031−28A2.90−30A2--AGGAC[A]{.ul}AACATTTTCTTCCATTTTTTTCCCCATAG−28A4TGACAA[A]{.ul}CATTTTCTTCCATTTTTTTCCCCATAG*G22P1*83212−26A2.50−31A2--AAGTC[A]{.ul}AATCAAAGAAAATTTATCTCCTTTCTTCAG−26A1TAAATC[A]{.ul}AAGAAAATTTATCTCCTTTCTTCAG−25A1TAATCA[A]{.ul}AGAAAATTTATCTCCTTTCTTCAG*G22P1*102978−33A3.60−33A10--GACTC[A]{.ul}CCAGGCCACTCTTCTGTGTTTTGATTT TCTAG*GAPDH*21633−26A3.35−6T10--TTGTC[T]{.ul}CTTAG*HSPA8*1734−39A3.15−23A1TTTTTA[A]{.ul}ACCAGATTTTTCTTTTTTTCAG−19A1--AAACC[A]{.ul}GATTTTTCTTTTTTTCAG−17A1CACCAG[A]{.ul}TTTTTCTTTTTTTCAG*HSPCB*6448−18A3.15−22A6TGTACC[A]{.ul}CTTATTTTTGGTTTCTTTCAG−23C1--TGTAC[C]{.ul}ACTTATTTTTGGTTTCTTTCAG*HSPCB*10777−22A3.20−24T1--CAATC[T]{.ul}AAGGCTTTTGTGATCGTCCACAG−22A2TATCTA[A]{.ul}GGCTTTTGTGATCGTCCACAG*HSPCB*11434−22A2.75−18A1TAATTA[A]{.ul}TGAGATTTTTATTTTAG*LDHB*27526−22A3.35−24T4--GGTTC[T]{.ul}AATGCCTGTTTTTGCGTTTACAG−23A1TGTTCT[A]{.ul}ATGCCTGTTTTTGCGTTTACAG−22A6TTTCTA[A]{.ul}TGCCTGTTTTTGCGTTTACAG*PGK1*15461−28A3.00−29G2--AAGTT[G]{.ul}ATCATGGTCTTGCATCTTTCTTTTTTAG−28A4TAGTTG[A]{.ul}TCATGGTCTTGCATCTTTCTTTTTTAG*PGK1*23826−35A3.00−26T4--CATTC[T]{.ul}GTTTGTTGTCTCTCTTTGGTTGCAG*PGK1*43151−29A3.35−33C1--GGAGC[C]{.ul}ATCACATTTTCTGTTTTTGTTTTTCTCTA TAG−29A5TCCATC[A]{.ul}CATTTTCTGTTTTTGTTTTTCTCTATAG*PGK1*5635−32A3.40−29A1TTGACT[A]{.ul}GAATCTGAATGTCTTTGATCTTTTCTAG−22G7--AATCT[G]{.ul}AATGTCTTTGATCTTTTCTAG−21A2TATCTG[A]{.ul}ATGTCTTTGATCTTTTCTAG*PGK1*64664−27A3.15−28A1TTCTTT[A]{.ul}AGTGATGATTCTTGCTTTCTCTTGTAG−23A8TAAGTG[A]{.ul}TGATTCTTGCTTTCTCTTGTAG*PGK1*81499−27A3.20−27A10TAGCTC[A]{.ul}TCTTCTCTTTCACCTCTACCCCTCAG*PGK1*10364−35A2.75−36A10--ATAGT[A]{.ul}ATGCTGTCTATGTATGTGTGCTCTCTC AAAAACAG*PKM2*21443−39A3.05−31A2TAATTA[A]{.ul}TACTTGTGGCTTTAAAACTTTTCCTAATAG−29A1TTTAAT[A]{.ul}CTTGTGGCTTTAAAACTTTTCCTAATAG−25G1CTACTT[G]{.ul}TGGCTTTAAAACTTTTCCTAATAG−23G1CCTTGT[G]{.ul}GCTTTAAAACTTTTCCTAATAG*PKM2*36930−21A2.75−25T3--ACGCT[T]{.ul}GTCATCTTCCTTCTTTTCCCCCAG−21A4TTTGTC[A]{.ul}TCTTCCTTCTTTTCCCCCAG*PKM2*4487−26A2.85−38T1--TGGTG[T]{.ul}CTCCAGTTTGGACTCTTGCTTACTCTCTTGT CCCTAG−33A1TTCTCC[A]{.ul}GTTTGGACTCTTGCTTACTCTCTTGTCC CTAG−23C1--GGACT[C]{.ul}TTGCTTACTCTCTTGTCCCTAG−16A1TTGCTT[A]{.ul}CTCTCTTGTCCCTAG−8G1--CTCTT[G]{.ul}TCCCTAG−5C1--TTGTC[C]{.ul}CTAG*PKM2*5781nana−32T1--CGTGC[T]{.ul}CTGCCTCCCCTACTTACCCTTTTTCATACAG−31C1--GTGCT[C]{.ul}TGCCTCCCCTACTTACCCTTTTTCATACAG−28C3--CTCTG[C]{.ul}CTCCCCTACTTACCCTTTTTCATACAG−20A1TCCCCT[A]{.ul}CTTACCCTTTTTCATACAG−18T1ACCTAC[T]{.ul}TACCCTTTTTCATACAG−16A2TTACTT[A]{.ul}CCCTTTTTCATACAG*PKM2*61343−29A3.10−39G1CCCTCT[G]{.ul}TTCTATATAACCTCTCTCCCCCCAACTTTG TCCATCAG−34A6TGTTCT[A]{.ul}TATAACCTCTCTCCCCCCAACTTTG TCCATCAG−32A2TTCTAT[A]{.ul}TAACCTCTCTCCCCCCAACTTTGTCCATCAG*PKM2*84107nana−65T2--CCTTT[T]{.ul}GTGACAAAGCTCTGACAAAGCTCTGTCCC CCTCTCGTCCCTCTGGACGGATGTTGCTCCCCTAG−52T1--AGCTC[T]{.ul}GACAAAGCTCTGTCCCCCTCTCGTCCCTC TGGACGGATGTTGCTCCCCTAG−50A5TCTCTG[A]{.ul}CAAAGCTCTGTCCCCCTCTCGTCCCTCTGGA CGGATGTTGCTCCCCTAG*PKM2*10717−25A3.75−27T1--TTTAC[T]{.ul}CACCAACCTCCCTTCTCTTCCTCCAG−26C2--TTACT[C]{.ul}ACCAACCTCCCTTCTCTTCCTCCAG−25A6TTACTC[A]{.ul}CCAACCTCCCTTCTCTTCCTCCAG*PSMB4*4393−40A3.05−44A4TCTGTT[A]{.ul}TTCAGCCCAATATCCCCCCATGGTTTTCC CCCAATCTCCCTAG−40A5TTATTC[A]{.ul}GCCCAATATCCCCCCATGGTTTTCCCCCA ATCTCCCTAG*RPL13*4583−21A3.30−26A1CACCCC[A]{.ul}CTTAACTCTTCTCATTCACCAACAG−23T1--CCACT[T]{.ul}AACTCTTCTCATTCACCAACAG−22A4TCACTT[A]{.ul}ACTCTTCTCATTCACCAACAG*RPL13*5492−22A3.30−22A9--GTTTA[A]{.ul}CAACCTGTCTTTCTCTTCTAG−20A1TTTAAC[A]{.ul}ACCTGTCTTTCTCTTCTAG*RPL13A*12205−26A3.55−22C7--GAGTC[C]{.ul}TTTTGCCCTTGTCTCCCACAG−8T1--TTGTC[T]{.ul}CCCACAG*RPL3*2770−21A3.70−21A4TGTCTG[A]{.ul}CTACTGCTTTTTTTTTGCAG−19T3--CTGAC[T]{.ul}ACTGCTTTTTTTTTGCAG*RPL3*41150−22A3.30−24T10--GGAGC[T]{.ul}GAGCTGTGTCTACCTTCTCCTAG*RPL3*5522−22A2.50−29T1--GGCGC[T]{.ul}GAGGTGAAGTAATGTGTATCCATTCCAG*RPL3*6477−34A3.45−22T3--AGCCT[T]{.ul}ACACCCTTCTTGTTCATTCAG−21A3TGCCTT[A]{.ul}CACCCTTCTTGTTCATTCAG*RPL8*4806nana−23C5--GTTCC[C]{.ul}TGAGGTATCTGATCCCCTACAG*SLC25A3*21591−30A2.85−31A1--ATATT[A]{.ul}AAATGCATGGTGTGTCTTCTCTTACTACAG*SNRPB*12929−24A3.20−24A1TGTCTC[A]{.ul}TCCCTGTCCATTTCTCCTTGCAG*SNRPB*21787−34A3.85−36T2--ACCTC[T]{.ul}AACACTTTTTTTGTTCCTTCTAAAC CTCTCTTTAG−35A5--CCTCT[A]{.ul}ACACTTTTTTTGTTCCTTCTAAACC TCTCTTTAG−34A2TCTCTA[A]{.ul}CACTTTTTTTGTTCCTTCTAAAC CTCTCTTTAG*SNRPB*31808−34A3.10−30G2--CACTG[G]{.ul}GCATCAGAGCATATTTGTTTATTT TTCAG−29G3--ACTGG[G]{.ul}CATCAGAGCATATTTGTTTATTTT TCAG−28C1GCTGGG[C]{.ul}ATCAGAGCATATTTGTTTATTTTTCAG−27A2--TGGGC[A]{.ul}TCAGAGCATATTTGTTTATTTTTCAG*SNRPB*4519−25A3.75−27T7--TCTTC[T]{.ul}AACTCTTTCTTCTTATGTCCTCTTAG−26A1TCTTCT[A]{.ul}ACTCTTTCTTCTTATGTCCTCTTAG−25A5TTTCTA[A]{.ul}CTCTTTCTTCTTATGTCCTCTTAG*SNRPB*6696−25A3.95−27T8--GGCAC[T]{.ul}GACTAAACTTCTTACTCTTACTTCAG*UBB*1717−33A3.45−30T6--TGAGG[T]{.ul}GACACGCTTATGTTTTACTTTTAAA CTAG−29G1--GAGGT[G]{.ul}ACACGCTTATGTTTTACTTTTAA ACTAG−28A2TAGGTG[A]{.ul}CACGCTTATGTTTTACTTTTAAACTAG[^7][^8]

The 367 clones were divided into two classes: 181 clones carrying misincorporated nucleotides at the branch points, and 186 clones without misincorporated nucleotides. For those carrying misincorporated nucleotides, we could pinpoint the exact branch points ([Figure 1](#F1){ref-type="fig"}A). On the other hand, for those carrying no misincorporated nucleotides, the reverse transcriptase might have skipped one or two nucleotides at the 2′--5′ phosphodiester bond at the branch points ([Figure 1](#F1){ref-type="fig"}B).

Among the 367 clones, we observed two or more possible branch sites in 36 of 52 introns. The 36 introns carried a total of 101 possible branch sites. Among the 101 sites, 25 were followed by an immediate downstream branch site, making 25 possible branch-site pairs. Among the 25 upstream branch sites, 19 carried no misincorporated nucleotides. In addition, 13 of the 19 upstream sites were followed by an 'A' nucleotide. Furthermore, when we simply deduced the consensus BPS from all 367 clones, the consensus BPS became more degenerative and less informative (data not shown). These findings suggest that the observed upstream branch points are likely due to skipping of a nucleotide in lariat RT-PCR. We thus employed the 181 clones carrying misincorporated nucleotides at the branch points in the following analyses unless otherwise stated.

We counted each clone as a single occurrence of a branch point in order to weigh the preferred branch points. For example, in *PGK1* intron 6, eight clones mapped to 'A' at position −23, whereas one clone pointed to 'A' at position −28 ([Table 3](#T3){ref-type="table"}). We assumed that the branch point at position −23 was eight times more frequently employed than that at position −28. This analysis method might have overweighed introns that gave rise to more clones. An alternative analysis method would be to make the contribution of each intron equal regardless of the number of available clones. The alternative method, however, is also biased in favor of introns with fewer clones. For example, *PGK1* intron 8 had a single available clone mapping to position −27, whereas *EEF1A1* intron 1 had ten clones all mapping to position −23. A single clone of *PGK1* might have arisen from one of many branch points, and we might have sequenced it by chance. On the other hand, it is likely that *EEF1A1* intron 1 indeed had a single branch point. We analyzed our data using both methods and obtained similar results (data not shown), except that the frequency of C at position −1 was slightly lower with the alternative method (44.8% versus 36.3%). In the current communication, we employed the former method, in which each clone was counted as a single occurrence of a branch site.

Positions and sequence motif of the branch points
-------------------------------------------------

Analysis of the 181 clones revealed that the positions of the branch points were from −50 to −5, where position −1 represents the 3′ end of an intron ([Figure 3](#F3){ref-type="fig"}A). Among the 181 sites, 150 (83%) were at positions −34 to −21. Figure 3.(**A**) Positions and nucleotides of 181 branch points with misincorporated nucleotides in our studies, where position −1 represents the 3′ end of an intron. The median value of the branch points is −26, and the mean and SD is −27.7 ± 7.6. Among the 181 sites with misincorporated nucleotides at the branch points, 150 sites (83%) are at positions −34 to −21 (horizontal bar on top). Native nucleotides, not the misincorporated nucleotides, are indicated. Nucleotide preferences (**B** and **D**) and information contents (**C** and **E**) are deduced from 181 branch points. (**B** and **C**) Plots are aligned in respect to the branch point (closed arrows), which is designated as position 0. Open arrows point to peaks of information contents at positions +7 and +8. A polypyrimidine stretch starts from position +4 down to position +24 (bars). The plots are truncated at position +25, because the numbers of observations fall below 40 after position +25, and the plots become less informative and uneven. The last three nucleotides of introns are excluded from the plots. (**D** and **E**) Plots are aligned in respect to the 3′ end of each intron, which is designated as position −1. A polypyrimidine stretch spans positions −19 to −5 (bars).

We observed U at position −2 in 74.6% branch sites, and A at position 0 in 92.3% branch sites ([Table 4](#T4){ref-type="table"}). In addition, pyrimidines were observed at positions −3 and +1 in 79.0% and 75.1% branch sites, respectively ([Table 4](#T4){ref-type="table"}). We can thus conclude that the human consensus BPS is yUn[A]{.ul}y at positions −3 to +1 ([Figure 2](#F2){ref-type="fig"}C), where the branch site is underlined and the less conserved nucleotides are indicated in lowercase letters. The information contents of 0.27 and 0.23 at positions −3 and +1, however, were not as high as those of 0.85 and 1.48 at positions −2 and 0 ([Figure 2](#F2){ref-type="fig"}D), or 0.39 ± 0.12 (mean ± SD) of the polypyrimidine tract at positions +4 to +24 ([Figure 3](#F3){ref-type="fig"}C). Therefore, the consensus sequence alternatively becomes Un[A]{.ul} according to the information contents ([Figure 2](#F2){ref-type="fig"}D). Table 4.Nucleotide frequencies at the 181 branch sitesPosition−5−4−3−2−10123A0.2540.2320.0830.0660.1660.9230.1820.3020.201C0.2100.2270.4700.1600.4480.0330.3310.2740.391G0.2540.1930.1270.0280.1770.0170.0660.1120.112U0.2820.3480.3200.7460.2100.0280.4200.3130.296

Among the 41 introns yielding the 181 clones, 14 introns carried multiple branch sites. In eight of the 14 introns (57%), the most downstream branch sites were most frequently used ([Table 3](#T3){ref-type="table"}). Although the ratio of 57% was not high, the downstream branch sites were four to eight times more frequently used than the upstream sites in four of the eight introns. We could not observe this magnitude of differential branch site usage in the remaining six introns, in which the downstream branch points were not overrepresented. Accordingly, when there are multiple branch points, downstream branch points are more likely to be employed than their upstream counterparts.

We also predicted BPSs of our housekeeping genes with the Branch Site Analyzer ([@B14]), and found that the actual branch sites matched to the predicted positions in 80 of the 181 sites (44.2%) ([Table 3](#T3){ref-type="table"}).

Alignment of polypyrimidine tract in respect to the branch point
----------------------------------------------------------------

We next aligned the PPT\'s in respect to the 181 branch points ([Figure 3](#F3){ref-type="fig"}B and C). We observed a polypyrimidine stretch from position +4 down to position +24. The 'U' nucleotide was preferred over 'C' especially at positions +4 to +12 in the PPT. Alignment of the PPT in respect to the 3′ end of an intron also demonstrated a stretch of pyrimidines from positions −20 to −4 ([Figure 3](#F3){ref-type="fig"}D and E). The information contents at the PPT\'s were similar between the two alignments. We observed peaks of information contents seven and eight nucleotides downstream of the branch point. The functional significance of these peaks, however, remains elusive.

Information obtained from lariat RT-PCR clones without misincorporated nucleotides
----------------------------------------------------------------------------------

We next asked if we could exploit the 186 clones without misincorporated nucleotides at the branch point. If there was an 'A' nucleotide one or two nucleotides downstream of the sequenced branch point and the sequenced branch point was not 'A', we assumed that one or two nucleotides were skipped by the reverse transcriptase and that the particular downstream 'A' was the actual branch point. A similar assumption has also been applied to three other genes in previous reports ([@B15; @B16; @B17]). We aligned the branch points under this assumption, and plotted the nucleotide preferences and the information contents ([Figure 2](#F2){ref-type="fig"}E and F). Compared to those of misincorporated nucleotides, the information contents were generally lower, but the Pictogram and WebLogo presentations resulted in similar patterns. These analyses suggest that one or two nucleotides were skipped when there were no misincorporated nucleotides, but definite experimental evidence is lacking to employ these clones to deduce the human consensus BPS.

DISCUSSION
==========

Highly degenerative human BPS
-----------------------------

We determined splicing branch points in 52 introns of 20 human housekeeping genes by lariat RT-PCR. Our analysis disclosed the following features ([Figure 4](#F4){ref-type="fig"}). First, 83% of the branch points are located 21--34 nucleotides upstream of the 3′ end of an intron ([Figure 3](#F3){ref-type="fig"}A). Second, a polypyrimidine stretch spans 4--24 nucleotides downstream of the branch point ([Figure 3](#F3){ref-type="fig"}B and C). Third, the human branch point consensus sequence is yUn[A]{.ul}y ([Figure 2](#F2){ref-type="fig"}C and D). The first and the second features underscore the previous *in silico* observations ([@B6],[@B14]), whereas the degeneracy of the human BPS is more than we have expected. Figure 4.Representative composition of the branch point sequence (arrow) and the PPT deduced from our studies.

It is interesting to note that among the six consensus BPSs proposed for the mammalian branch points ([Table 1](#T1){ref-type="table"}), the shared nucleotides are yUn[A]{.ul}y, which is identical to that determined by our analysis.

SF1 binds to BPS using its KH domain ([@B18]). NMR analysis of SF1 bound to the BPS revealed that a hydrophobic motif of Gly-Pro-Arg-Gly within the KH domain builds hydrogen bonds with 'UA[A]{.ul}' at positions −2 to 0 of the yeast BPS, 'UACUA[A]{.ul}C' ([@B19]). Our analysis suggests that the binding of the KH domain to position −1 may enhance, but may be dispensable for, the recognition of the BPS. Berglund and colleagues ([@B20]) also demonstrate that, in 'UACUA[A]{.ul}C' at positions −5 to +1, nucleotide substitutions only at position −2 or 0, but not at the other positions, compromise the binding of SF1.

Non-'A' nucleotides at position 0
---------------------------------

We observed an 'A' nucleotide at 92.3% of the branch points. Non-'A' nucleotides at the branch point have been reported in *CALCA1* ([@B21]) and *GH1* ([@B22]) ([Table 2](#T2){ref-type="table"}). The two reports demonstrate six such examples in four introns. As these unusual branch points constitute 21% (6/29) of the previously reported *in vitro* determined branch points, the ratio of 'A' at the branch point is reduced to 79% ([Table 2](#T2){ref-type="table"}). Additionally, the potential observation bias posed by these unusual BPSs may account for the differences in the Pictogram and WebLogo patterns between the previously identified BPSs ([Figure 2](#F2){ref-type="fig"}A and B) and our BPSs ([Figure 2](#F2){ref-type="fig"}C and D).

Disease-causing mutations disrupting BPSs
-----------------------------------------

According to the Human Gene Mutation Database ([@B23]), splicing mutations account for 13.7% (1768 of 12 879) of single nucleotide substitutions. Most splicing mutations, however, are at the splice donor or acceptor sites. To our knowledge, sixteen disease-causing mutations and a single polymorphism disrupt BPSs and give rise to aberrant splicings ([Table 5](#T5){ref-type="table"}). Nine variants are at position 0, and the other eight are at position −2. Among the nine variants affecting position 0, seven are A-to-G mutations, which supports the notion reported by Kralovicova and colleagues ([@B24]) that A-to-G transitions at position 0 are more deleterious than A-to-T or A-to-C transversions. For all the variants, aberrant splicings have been determined either in patients or minigenes. The actual branch points, however, have been identified only in two variants by lariat RT-PCR, whereas the remaining fourteen variants have been mapped to putative BPSs. Exclusive confinement of BPS-disrupting nucleotide changes at positions −2 and 0 also underscores our observation that the BPS consensus is yUn[A]{.ul}y. Table 5.Sixteen mutations and a single polymorphism disrupting BPSsGene and intronSequenceConsequenceReference*LCAT* intron4Wild-typeCCCTGACMutantCCC[C]{.ul}GACIntron retention^a^([@B43],[@B44])MutantCCC[G]{.ul}GACIntron retention^b^([@B45])MutantCCC[A]{.ul}GACIntron retention^b^([@B45])*FBN2* intron30Wild-typeTACTAAGMutantTAC[G]{.ul}AAGExon skipping^a^([@B46])*COL5A1* intron32Wild-typeGACTGACMutantGAC[G]{.ul}GACExon skipping^a^([@B47])*ITGB4* intron31Wild-typeGGCTCACMutantGGC[A]{.ul}CACIntron retention,^a^ cryptic 3′ splice site^a^([@B48])*TH* intron10Wild-typeGGCTGATMutantGGC[A]{.ul}GATExon skipping,^a^ cryptic 3′ splice site^a^([@B49])*L1CAM* intron18Wild-typeATCCAAGMutantATCCA[C]{.ul}Gcryptic 3′ splice site^a^([@B50])*LIPC* intron1Wild-typeCCCCAATMutantCCCCA[G]{.ul}Tcryptic 3′ splice site^a^([@B51])*FBN2* intron28Wild-typeTTGCAATMutantTTGCA[G]{.ul}TExon skipping^a^([@B52])*HEXB* intron10Wild-typeTTGCAATMutantTTGCA[G]{.ul}TCryptic 3′ splice site^a^([@B53])*NF2* intron5Wild-typeTTCTAGCMutantTTCTA[A]{.ul}CIntron retention^a^([@B54])*TSC2* intron38Wild-typeGCGTGACMutantGCGTG[G]{.ul}CCryptic 3′ splice site,^a^ intron retention^a^([@B55])*XPC* intron3^c^Wild-typeTACTGATMutantTACTG[G]{.ul}TExon skipping^a^([@B16])*NPC1* intron6Wild-typeCACTAATMutantCACTA[G]{.ul}TExon skipping^a^([@B56])*F9* intron 2Wild-typeCGTTAATMutantCGTTA[G]{.ul}TExon skipping^b^([@B24],[@B57])*DQB1* intron 3^c,d^Genotype ACAC[A]{.ul}GACExon skipping^b^([@B17])Genotype UCAC[U]{.ul}GACExon inclusion^b^([@B17])[^9][^10][^11]

Conversely, mutations disrupting yUn[A]{.ul}y are not always deleterious. When the branch point 'A' is mutated or deleted, a neighboring cryptic 'A' residue is employed as a branch point ([@B25; @B26; @B27]), or the mutant 'C', 'G' or 'U' residue is used as a surrogate branch point ([@B28]). Additionally, we observed two or more branch sites in 15 of 41 introns ([Table 3](#T3){ref-type="table"}), which also implies that a mutation-harboring BPS can be readily substituted for by another BPS.

How is the highly degenerative BPS recognized?
----------------------------------------------

It is hard to believe that SF1 simply recognizes yUn[A]{.ul}y. We expect that SF1 recognizes the BPS along with the other *cis*-element(s) and their interacting *trans*-factor(s).

The SELEX screening of the yeast BBP binding motifs revealed a stem and loop structure immediately upstream of the BPS of 'UACUA[A]{.ul}C' in 9 out of 48 selected motifs ([@B29]). A gel shift assay also showed preferential binding of human SF1 to 'UACUA[A]{.ul}C' carrying an upstream stem and loop. Our BPSs, however, had no upstream stem and loop structures (data not shown). An upstream stem and loop may help recognize highly degenerative mammalian BPSs for a subset of introns.

In the early step of the spliceosome assembly, SF1, U2AF65 and U2AF35 bind to the BPS, the PPT and AG at the 3′ end of an intron, respectively, to form complex E ([@B1],[@B2]). In *S. pombe*, SF1/BBP is tightly associated with U2AF59, a yeast homolog of mammalian U2AF65 recognizing the PPT, as well as with U2AF23, a yeast homolog of mammalian U2AF35 recognizing the 3′ AG ([@B30]). In mammals, the association between SF1 and U2AF65 is mediated by the 28 N-terminal amino acids of the KH domain of SF1([@B31]) and by the third RBD of U2AF65 ([@B32]). Wang and colleagues determined that Ser20 in the N-terminal region of the KH domain is essential for binding to U2AF65 and that phosphorylation of Ser20 inhibits its binding and formation of complex A ([@B33]). Berglund and colleagues also report that the SF1-U2AF65 interaction promotes cooperative binding to the BPS and the PPT ([@B32]). Our analysis also demonstrates positional association of the BPS and the PPT ([Figure 3](#F3){ref-type="fig"}B and C). On the other hand, Kent and colleagues demonstrate that U2AF65 and U2AF35 are dispensable for the binding of SF1 to the BPS ([@B34]). Sharma and colleagues similarly show that complex H includes SF1 in the absence of U2AF65 and U2AF35 ([@B35]). Although the exact order of the SF1, U2AF65 and U2AF35 assembly remains elusive, the BPS is possibly recognized along with the PPT and the 3′ AG. Alternatively, SF1 is bound to any yUn[A]{.ul}y sequences in complex H, and a particular SF1 that successfully associates with the U2AF heterodimer exclusively survives to form complex E.

SUPPLEMENTARY DATA
==================

Supplementary Data are available at NAR Online.
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[^1]: Branch point 'A' is underlined. Y, U or C; R, A or G; S, G or C; V, A, C or G.

[^2]: ^a^Low GC% region.

[^3]: ^b^High GC% region.

[^4]: ^a^Predicted BPs and BPS scores are according to the Branch-Site Analyzer at <http://ast.bioinfo.tau.ac.il/BranchSite.htm> ([@B14]). na, not available.

[^5]: ^b^Identified by the primer extension method.

[^6]: ^c^Identified by lariat RT-PCR.

[^7]: ^a^Predicted BPs and BPS scores are according to the Branch-Site Analyzer at <http://ast.bioinfo.tau.ac.il/BranchSite.htm> ([@B14]).

[^8]: ^b^Observed branch sites are underlined.

[^9]: Mutations or a polymorphism are underlined. Aberrant splicings have been determined in patients^a^ or minigenes^b^.

[^10]: ^c^Branch points have been identified by lariat RT-PCR. Others are putative BPSs lacking *in vitro* evidence.

[^11]: ^d^Polymorphism.
